NeuBase Therapeutics, Inc. ( NASDAQ:NBSE – Get Rating ) saw a large decline in short interest in June. As of June 15th, there was short interest totalling 34,300 shares, a decline of 93.8% from the May 31st total of 554,800 shares. Based on an average trading volume of 62,600 shares, the days-to-cover ratio is presently 0.5 days. Approximately 2.4% of the shares of the stock are short sold. NeuBase Therapeutics Stock Performance Shares of NBSE traded down $0.10 during mid-day trading on Wednesday, hitting $2.

https://www.dailypolitical.com/2023/06/28/neubase-therapeutics-inc-nasdaqnbse-sees-large-decrease-in-short-interest.html

#dailypolitical